Study adaptive, randomized, open, controlled, multicenter Phase I-II, of HEBERFERON use in patients with renal cell carcinoma stage III-IV

Trial Profile

Study adaptive, randomized, open, controlled, multicenter Phase I-II, of HEBERFERON use in patients with renal cell carcinoma stage III-IV

Not yet recruiting
Phase of Trial: Phase I/II

Latest Information Update: 17 Jan 2017

At a glance

Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top